AUTHOR=Peng Ning , Mao Lin-Feng , Su Jia-Yong , Liu Shao-Ping , Ou Jun-Jie , Chen Shu-Chang , Su Ze , Li Wen-Feng , Yang Fu-Quan , Zhou Yong-Heng , Li Le , Zhong Jian-Hong 

TITLE=Correction: The efficacy and safety of tislelizumab with or without tyrosine kinase inhibitor as adjuvant therapy in hepatocellular carcinoma with high-risk of recurrence after curative resection

JOURNAL=Frontiers in Immunology

VOLUME=Volume 16 - 2025

YEAR=2025

URL=https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1669840

DOI=10.3389/fimmu.2025.1669840

ISSN=1664-3224